oxidative

6B – Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC

[gdlr_button href=”https://www.consultdranderson.com/wp-content/uploads/securepdfs/2019/10/6B-2019-IVC-Ascorbate-Leukemia-Update.pdf” target=”_blank” size=”large” background=”#ed4b2f” color=”#ffffff”]Download PDF[/gdlr_button] A seeming conundrum regarding the ability of some leukemic cells (i.e. CLL) to sequester ascorbate (ASC) has led to confusion regarding the safety and utility of high dose ascorbate delivered via IV (HDIVC).  This has led to some apparent confusion between this concern and the apparent positive benefits …

6B – Leukemia and Oxidative Therapies Including Intravenous Ascorbic Acid / HDIVC Read More »

Separating Intravenous Ascorbic Acid [IV Ascorbate] and Glutathione on the same Day in Oxidative Therapies. Rationale and limitations of clinical timing.

Dr. Paul S. Anderson While non-oxidant doses of intravenous vitamin c (IVC) and glutathione (GSH) are synergistic in support of the ReDox cascade between physiological compartments (Cytosol-Cell Membrane-Plasma-Plasma Lipids)* it was previously theorized that an oxidant therapy such as high dose IVC (HDIVC) may be defeated by addition of GSH in proximity. Chen et. al …

Separating Intravenous Ascorbic Acid [IV Ascorbate] and Glutathione on the same Day in Oxidative Therapies. Rationale and limitations of clinical timing. Read More »

Scroll to Top